COMP <GO>
FBIO vs RNXT // PIOTROSKI F-SCORE QUALITY
Fortress Biotech Inc. (NASDAQ) VS. RenovoRx Inc. (NASDAQ) • 15-METRIC TALLY: FBIO 3
— RNXT 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: FBIO
LAST: $1.92 (-4.00%) • MKT CAP: $66.7M
piotroski-score
5/9
LAST: $1.33 (-10.74%) • MKT CAP: $67.2M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FBIO VS. RNXT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FBIO | RNXT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.90% | 70.90% | -4.00 | RNXT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -16.32% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | 58.50% | -60.00% | +118.50 | FBIO | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | 180.00% | -170.30 | RNXT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.00% | 0.00% | +1.00 | FBIO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.40 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 5/9 | 4/9 | +1.00 | FBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.7 | 47.1 | -8.43 | RNXT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $66.7M | $67.2M | -$541.0K | RNXT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FBIO REV | RNXT REV | FBIO GROSS % | RNXT GROSS % | FBIO FCF | RNXT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $63.3M | $1.1M | 66.9% | 70.9% | -$65.8M | -$11.0M |
| FY 2024 | $57.7M | $43.0K | 63.8% | 98.0% | -$80.2M | -$9.1M |
| FY 2023 | $84.5M | $0 | — | — | -$128.2M | -$10.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FBIO // BETA —
RNXT // BETA —